“Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata”, J of Skin, vol. 7, no. 6, p. s295, Nov. 2023, doi: 10.25251/skin.7.supp.295.